Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R. Robinson, Arul M. Chinnaiyan, Yi-Mi Wu et al.|Nature Genetics|2013Cited by 1.2k
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot StudySameek Roychowdhury, Arul M. Chinnaiyan, Matthew K. Iyer et al.|Science Translational Medicine|2011Cited by 637
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceYue Zhao, Joshy George, Stephen B. Fox et al.|EBioMedicine|2020Cited by 134
Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b studyMatthew S. Davids, Jennifer R. Brown, Haesook T. Kim et al.|The Lancet Haematology|2018Cited by 115
TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib StudyMatthew S. Davids, Jennifer R. Brown, Haesook T. Kim et al.|Blood|2016Cited by 15